Agroecological management of insect pests on sugarbeets and lettuce cultivated in organic farming

Two-year field trials were conducted in northern Italy with the aim of developing a trapcrop-based agroecological approach for the control of flea beetles (Chaetocnema tibialis (Illiger), Phyllotreta spp. (Chevrolat) (Coleoptera: Chrysomelidae)) and Lygus rugulipennis Poppius (Hemiptera: Miridae), key pests of sugar beet and lettuce, respectively. Flea beetle damage trials compared a trap cropping treatment, i.e., a sugar beet plot with a border of Sinapis alba (L.) and Brassica juncea (L.) with a control treatment, i.e., a sugar beet plot with bare soil as field border. Sugar beets grown near trap crops showed a significant decrease (≈40%) in flea beetle damage compared to control. Moreover, flea beetle damage varied with distance from the edge of the trap plants, being highest at 2 m from the edge, then decreasing at higher distances. Regarding L. rugulipennis on lettuce two experiments were conducted. A semiochemical-assisted trap cropping trial was supported by another test evaluating the efficacy of pheromones and trap placement. In this trial, it was found that pheromone baited traps caught significantly more specimens of L. rugulipennis than unbaited traps. It was also found that traps placed at ground level produced larger catches than traps placed at the height of 70 cm. In the semiochemical-assisted trap cropping experiment, a treatment where lettuce was grown next to two Alfa-Alfa borders containing pheromone baited traps was compared with a control treatment, where lettuce was grown near bare soil. This experiment showed that the above-mentioned strategy managed to reduce L. rugulipennis damage to lettuce by ≈30%. From these studies, it appears that trap crop-based strategy, alone or with baited traps, made it possible to reduce crop damage to economically acceptable levels and to minimize the need for insecticide treatments, showing that those strategy could be implemented in organic farming as a means of controlling insect pests.

Neuroprotective role of nutraceutical and phytochemical components

Neurodegenerative diseases (NDs) are characterized by a multifactorial etiology, in which oxidative stress and inflammation are the main causative factors. For this reason, increasing attention is being paid to the characterization and the identification of nutraceuticals and phytochemicals with intrinsic pleiotropic activity. Moreover, in a Circular Economy perspective, these natural compounds can be obtained also from renewable resources derived from the food industry by-products and can be used for both preventive and therapeutic purposes. The aim of this PhD program was to identify nutraceuticals and phytochemicals, both as extracts and pure compounds, and obtained from both plant and renewable sources, which due to their antioxidant and anti-inflammatory properties, were able to counteract cellular and molecular alterations that characterize NDs. Their neuroprotective potential has been evaluated in an in vitro model of neuroinflammation (the LPS-activated BV-2 microglial cell line), and/or in an in vitro model of neuronal oxidative stress (the neuron-like SH-SY5Y cell line differentiated with retinoic acid and exposed to H2O2). Four different projects, although deeply linked by the aforementioned common goal, have been discussed in this thesis: 1_ Impact of phenolic profile of different cherry cultivars on the potential neuroprotective effect in SH-SY5Y cells. 2_Anti-inflammatory activities of Spilanthol-rich essential oil from Acmella oleracea (L.). 3_Study of the anti-inflammatory activity of novel tacrine derivatives with lipids extracted from cashew nutshell liquid. 4_Coffee Silverskin (CSS) and Spent Coffee Grounds (SCG): coffee industry by-products as a promising source of neuroprotective agents. In general, it is, therefore, possible to conclude that the natural compounds studied in this thesis have been proven, due to their antioxidant and/or anti-inflammatory properties, to be valid preventive and therapeutic strategies for the treatment of NDs, to improve the life quality of these patients and of the general population by preventing and combating the onset of these deleterious diseases.